ONQUELVA
Live / Registered — Registered (as of 20 Jan 2026)
What this means for you
Registered since 20 Jan 2026. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97244486
- Registration number
- 8105964
- Mark type
- Stylized text
- Filed
- 28 Jan 2022
- Published for opposition
- 08 Nov 2022
- Registered
- 20 Jan 2026
- Attorney of record
- Boris Umansky
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and prevention of cancer, oncological diseases, leukemia, musculoskeletal disorders, muscular dystrophy, pseudoxanthoma, dermatological disorders, allergy, cardiovascular diseases, kidney diseases, fibrodysplasia ossificans progressiva; Vaccines
Owner
- DAIICHI SANKYO COMPANY, LIMITED, Chuo-ku, Tokyo, JP
- DAIICHI SANKYO COMPANY, LIMITED, Chuo-ku, Tokyo, JP
- DAIICHI SANKYO COMPANY, LIMITED, Chuo-ku, Tokyo, JP
Prosecution history
- 20 Jan 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 20 Jan 2026 — REGISTERED-PRINCIPAL REGISTER
- 29 Dec 2025 — 1(B) BASIS DELETED; PROCEED TO REGISTRATION
- 24 Dec 2025 — NOTICE OF ALLOWANCE CANCELLED
- 24 Dec 2025 — TEAS DELETE 1(B) BASIS RECEIVED
- 08 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Dec 2025 — SOU EXTENSION 5 GRANTED
- 10 Jun 2025 — SOU EXTENSION 5 FILED
- 05 Dec 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 11 Jun 2025 — SOU TEAS EXTENSION RECEIVED
- 27 Dec 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Dec 2024 — SOU EXTENSION 4 GRANTED
- 27 Dec 2024 — SOU EXTENSION 4 FILED
- 27 Dec 2024 — SOU TEAS EXTENSION RECEIVED
- 13 Jun 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED